| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| AMGN - Amgen Inc | BUY | 478 @ USD 345.46 | USD 165,130 | The ETF bought 478 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 345.46 compared to the previous average buy price of 291.965. This is 18.3% higher than average price of previous purchases of AMGN. |
| GILD - Guild Esports Plc | BUY | 1,218 @ USD 125.84 | USD 153,273 | The ETF bought 1218 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 125.84 compared to the previous average buy price of 114.096. This is 10.3% higher than average price of previous purchases of GILD. |
| VRTX - Vertex Pharmaceuticals Inc | BUY | 352 @ USD 433.61 | USD 152,631 | The ETF bought 352 new shares of VRTX (Vertex Pharmaceuticals Inc). The shares were bought for an average price of 433.61 compared to the previous average buy price of 416.603. This is 4.1% higher than average price of previous purchases of VRTX. |
| REGN - Regeneron Pharmaceuticals Inc | BUY | 172 @ USD 780.19 | USD 134,193 | The ETF bought 172 new shares of REGN (Regeneron Pharmaceuticals Inc). The shares were bought for an average price of 780.19 compared to the previous average buy price of 634.432. This is 23.0% higher than average price of previous purchases of REGN. |
| ALNY - Alnylam Pharmaceuticals Inc | BUY | 216 @ USD 451.23 | USD 97,466 | The ETF bought 216 new shares of ALNY (Alnylam Pharmaceuticals Inc). The shares were bought for an average price of 451.23 compared to the previous average buy price of 381.556. This is 18.3% higher than average price of previous purchases of ALNY. |
| AZN - AstraZeneca PLC | BUY | 861 @ USD 92.72 | USD 79,832 | The ETF bought 861 new shares of AZN (AstraZeneca PLC). The shares were bought for an average price of 92.72 compared to the previous average buy price of 76.185. This is 21.7% higher than average price of previous purchases of AZN. |
| INSM - Insmed Inc | BUY | 351 @ USD 207.77 | USD 72,927 | The ETF bought 351 new shares of INSM (Insmed Inc). The shares were bought for an average price of 207.77 compared to the previous average buy price of 127.296. This is 63.2% higher than average price of previous purchases of INSM. |
| ARGX - argenx NV ADR | BUY | 51 @ USD 911.98 | USD 46,511 | The ETF bought 51 new shares of ARGX (argenx NV ADR). The shares were bought for an average price of 911.98 compared to the previous average buy price of 666.48. This is 36.8% higher than average price of previous purchases of ARGX. |
| BIIB - Biogen Inc | BUY | 244 @ USD 182.09 | USD 44,430 | The ETF bought 244 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 182.09 compared to the previous average buy price of 141.545. This is 28.6% higher than average price of previous purchases of BIIB. |
| UTHR - United Therapeutics Corporation | BUY | 75 @ USD 486 | USD 36,450 | The ETF bought 75 new shares of UTHR (United Therapeutics Corporation). The shares were bought for an average price of 486 compared to the previous average buy price of 355.528. This is 36.7% higher than average price of previous purchases of UTHR. |
| INCY - Incyte Corporation | BUY | 325 @ USD 104.46 | USD 33,950 | The ETF bought 325 new shares of INCY (Incyte Corporation). The shares were bought for an average price of 104.46 compared to the previous average buy price of 77.0648. This is 35.5% higher than average price of previous purchases of INCY. |
| ILMN - Illumina Inc | BUY | 255 @ USD 131.45 | USD 33,520 | The ETF bought 255 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 131.45 compared to the previous average buy price of 99.9624. This is 31.5% higher than average price of previous purchases of ILMN. |
| RPRX - Royalty Pharma Plc | BUY | 717 @ USD 40.02 | USD 28,694 | The ETF bought 717 new shares of RPRX (Royalty Pharma Plc). The shares were bought for an average price of 40.02 compared to the previous average buy price of 35.9837. This is 11.2% higher than average price of previous purchases of RPRX. |
| MEDP - Medpace Holdings Inc | BUY | 47 @ USD 592.46 | USD 27,846 | The ETF bought 47 new shares of MEDP (Medpace Holdings Inc). The shares were bought for an average price of 592.46 compared to the previous average buy price of 414.113. This is 43.1% higher than average price of previous purchases of MEDP. |
| NBIX - Neurocrine Biosciences Inc | BUY | 165 @ USD 152.16 | USD 25,106 | The ETF bought 165 new shares of NBIX (Neurocrine Biosciences Inc). The shares were bought for an average price of 152.16 compared to the previous average buy price of 131.164. This is 16.0% higher than average price of previous purchases of NBIX. |
| RVMD - Revolution Medicines Inc | BUY | 312 @ USD 77.76 | USD 24,261 | The ETF bought 312 new shares of RVMD (Revolution Medicines Inc). The shares were bought for an average price of 77.76 compared to the previous average buy price of 44.1946. This is 75.9% higher than average price of previous purchases of RVMD. |
| ROIV - Roivant Sciences Ltd | BUY | 1,133 @ USD 20.81 | USD 23,578 | The ETF bought 1133 new shares of ROIV (Roivant Sciences Ltd). The shares were bought for an average price of 20.81 compared to the previous average buy price of 13.6907. This is 52.0% higher than average price of previous purchases of ROIV. |
| BBIO - BridgeBio Pharma Inc | BUY | 319 @ USD 72.01 | USD 22,971 | The ETF bought 319 new shares of BBIO (BridgeBio Pharma Inc). The shares were bought for an average price of 72.01 compared to the previous average buy price of 46.9521. This is 53.4% higher than average price of previous purchases of BBIO. |
| GH - Guardant Health Inc | BUY | 208 @ USD 108.42 | USD 22,551 | The ETF bought 208 new shares of GH (Guardant Health Inc). The shares were bought for an average price of 108.42 compared to the previous average buy price of 59.7067. This is 81.6% higher than average price of previous purchases of GH. |
| SNY - Sanofi ADR | BUY | 447 @ USD 49.88 | USD 22,296 | The ETF bought 447 new shares of SNY (Sanofi ADR). The shares were bought for an average price of 49.88 compared to the previous average buy price of 50.0556. This is -0.4% lower than average price of previous purchases of SNY. |
| SMMT - Summit Therapeutics PLC | BUY | 1,237 @ USD 17.89 | USD 22,130 | The ETF bought 1237 new shares of SMMT (Summit Therapeutics PLC). The shares were bought for an average price of 17.89 compared to the previous average buy price of 21.0725. This is -15.1% lower than average price of previous purchases of SMMT. |
| MDGL - Madrigal Pharmaceuticals Inc | BUY | 37 @ USD 596.98 | USD 22,088 | The ETF bought 37 new shares of MDGL (Madrigal Pharmaceuticals Inc). The shares were bought for an average price of 596.98 compared to the previous average buy price of 369.265. This is 61.7% higher than average price of previous purchases of MDGL. |
| IONS - Ionis Pharmaceuticals Inc | BUY | 266 @ USD 82.73 | USD 22,006 | The ETF bought 266 new shares of IONS (Ionis Pharmaceuticals Inc). The shares were bought for an average price of 82.73 compared to the previous average buy price of 51.0314. This is 62.1% higher than average price of previous purchases of IONS. |
| ASND - Ascendis Pharma AS | BUY | 101 @ USD 212.33 | USD 21,445 | The ETF bought 101 new shares of ASND (Ascendis Pharma AS). The shares were bought for an average price of 212.33 compared to the previous average buy price of 181.107. This is 17.2% higher than average price of previous purchases of ASND. |
| VTRS - Viatris Inc | BUY | 1,945 @ USD 10.69 | USD 20,792 | The ETF bought 1945 new shares of VTRS (Viatris Inc). The shares were bought for an average price of 10.69 compared to the previous average buy price of 9.68554. This is 10.4% higher than average price of previous purchases of VTRS. |
| EXEL - Exelixis Inc | BUY | 447 @ USD 44.17 | USD 19,744 | The ETF bought 447 new shares of EXEL (Exelixis Inc). The shares were bought for an average price of 44.17 compared to the previous average buy price of 41.1499. This is 7.3% higher than average price of previous purchases of EXEL. |
| JAZZ - Jazz Pharmaceuticals PLC | BUY | 101 @ USD 176.53 | USD 17,830 | The ETF bought 101 new shares of JAZZ (Jazz Pharmaceuticals PLC). The shares were bought for an average price of 176.53 compared to the previous average buy price of 127.33. This is 38.6% higher than average price of previous purchases of JAZZ. |
| BMRN - Biomarin Pharmaceutical Inc | BUY | 318 @ USD 55.93 | USD 17,786 | The ETF bought 318 new shares of BMRN (Biomarin Pharmaceutical Inc). The shares were bought for an average price of 55.93 compared to the previous average buy price of 57.9403. This is -3.5% lower than average price of previous purchases of BMRN. |
| BNTX - BioNTech SE | BUY | 167 @ USD 103.15 | USD 17,226 | The ETF bought 167 new shares of BNTX (BioNTech SE). The shares were bought for an average price of 103.15 compared to the previous average buy price of 104.923. This is -1.7% lower than average price of previous purchases of BNTX. |
| MRNA - Moderna Inc | BUY | 646 @ USD 25.98 | USD 16,783 | The ETF bought 646 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 25.98 compared to the previous average buy price of 28.8143. This is -9.8% lower than average price of previous purchases of MRNA. |
| RNA - Avidity Biosciences Inc | BUY | 213 @ USD 71.7 | USD 15,272 | The ETF bought 213 new shares of RNA (Avidity Biosciences Inc). The shares were bought for an average price of 71.7 compared to the previous average buy price of 40.4255. This is 77.4% higher than average price of previous purchases of RNA. |
| HALO - Halozyme Therapeutics Inc | BUY | 194 @ USD 71.4 | USD 13,852 | The ETF bought 194 new shares of HALO (Halozyme Therapeutics Inc). The shares were bought for an average price of 71.4 compared to the previous average buy price of 60.7917. This is 17.5% higher than average price of previous purchases of HALO. |
| CYTK - Cytokinetics Inc | BUY | 198 @ USD 68.13 | USD 13,490 | The ETF bought 198 new shares of CYTK (Cytokinetics Inc). The shares were bought for an average price of 68.13 compared to the previous average buy price of 45.0807. This is 51.1% higher than average price of previous purchases of CYTK. |
| AXSM - Axsome Therapeutics Inc | BUY | 83 @ USD 151.5 | USD 12,575 | The ETF bought 83 new shares of AXSM (Axsome Therapeutics Inc). The shares were bought for an average price of 151.5 compared to the previous average buy price of 117.902. This is 28.5% higher than average price of previous purchases of AXSM. |
| NUVL - Nuvalent Inc | BUY | 111 @ USD 109.35 | USD 12,138 | The ETF bought 111 new shares of NUVL (Nuvalent Inc). The shares were bought for an average price of 109.35 compared to the previous average buy price of 84.4469. This is 29.5% higher than average price of previous purchases of NUVL. |
| ARWR - Arrowhead Pharmaceuticals Inc | BUY | 230 @ USD 52.7 | USD 12,121 | The ETF bought 230 new shares of ARWR (Arrowhead Pharmaceuticals Inc). The shares were bought for an average price of 52.7 compared to the previous average buy price of 23.254. This is 126.6% higher than average price of previous purchases of ARWR. |
| MRUS - Merus BV | BUY | 126 @ USD 96.14 | USD 12,114 | The ETF bought 126 new shares of MRUS (Merus BV). The shares were bought for an average price of 96.14 compared to the previous average buy price of 66.9798. This is 43.5% higher than average price of previous purchases of MRUS. |
| RYTM - Rhythm Pharmaceuticals Inc | BUY | 111 @ USD 109.09 | USD 12,109 | The ETF bought 111 new shares of RYTM (Rhythm Pharmaceuticals Inc). The shares were bought for an average price of 109.09 compared to the previous average buy price of 78.3311. This is 39.3% higher than average price of previous purchases of RYTM. |
| PTCT - PTC Therapeutics Inc | BUY | 132 @ USD 85.99 | USD 11,351 | The ETF bought 132 new shares of PTCT (PTC Therapeutics Inc). The shares were bought for an average price of 85.99 compared to the previous average buy price of 57.1744. This is 50.4% higher than average price of previous purchases of PTCT. |
| PCVX - Vaxcyte Inc | BUY | 216 @ USD 49.61 | USD 10,716 | The ETF bought 216 new shares of PCVX (Vaxcyte Inc). The shares were bought for an average price of 49.61 compared to the previous average buy price of 44.9144. This is 10.5% higher than average price of previous purchases of PCVX. |
| KRYS - Krystal Biotech Inc | BUY | 48 @ USD 218 | USD 10,464 | The ETF bought 48 new shares of KRYS (Krystal Biotech Inc). The shares were bought for an average price of 218 compared to the previous average buy price of 165.577. This is 31.7% higher than average price of previous purchases of KRYS. |
| PTGX - Protagonist Therapeutics Inc | BUY | 104 @ USD 90 | USD 9,360 | The ETF bought 104 new shares of PTGX (Protagonist Therapeutics Inc). The shares were bought for an average price of 90 compared to the previous average buy price of 59.3983. This is 51.5% higher than average price of previous purchases of PTGX. |
| COGT - Cogent Biosciences Inc | BUY | 230 @ USD 40.22 | USD 9,251 | The ETF bought 230 new shares of COGT (Cogent Biosciences Inc). The shares were bought for an average price of 40.22 compared to the previous average buy price of 13.2009. This is 204.7% higher than average price of previous purchases of COGT. |
| ALKS - Alkermes Plc | BUY | 275 @ USD 29.58 | USD 8,134 | The ETF bought 275 new shares of ALKS (Alkermes Plc). The shares were bought for an average price of 29.58 compared to the previous average buy price of 30.286. This is -2.3% lower than average price of previous purchases of ALKS. |
| KYMR - Kymera Therapeutics Inc | BUY | 119 @ USD 67.88 | USD 8,078 | The ETF bought 119 new shares of KYMR (Kymera Therapeutics Inc). The shares were bought for an average price of 67.88 compared to the previous average buy price of 48.3912. This is 40.3% higher than average price of previous purchases of KYMR. |
| CRSP - Crispr Therapeutics AG | BUY | 151 @ USD 53.47 | USD 8,074 | The ETF bought 151 new shares of CRSP (Crispr Therapeutics AG). The shares were bought for an average price of 53.47 compared to the previous average buy price of 52.622. This is 1.6% higher than average price of previous purchases of CRSP. |
| ADMA - ADMA Biologics Inc | BUY | 400 @ USD 19.18 | USD 7,672 | The ETF bought 400 new shares of ADMA (ADMA Biologics Inc). The shares were bought for an average price of 19.18 compared to the previous average buy price of 17.3947. This is 10.3% higher than average price of previous purchases of ADMA. |
| AKRO - Akero Therapeutics Inc | BUY | 133 @ USD 54.36 | USD 7,230 | The ETF bought 133 new shares of AKRO (Akero Therapeutics Inc). The shares were bought for an average price of 54.36 compared to the previous average buy price of 49.6794. This is 9.4% higher than average price of previous purchases of AKRO. |
| CRNX - Crinetics Pharmaceuticals Inc | BUY | 157 @ USD 45.56 | USD 7,153 | The ETF bought 157 new shares of CRNX (Crinetics Pharmaceuticals Inc). The shares were bought for an average price of 45.56 compared to the previous average buy price of 35.7325. This is 27.5% higher than average price of previous purchases of CRNX. |
| SRRK - Scholar Rock Holding Corp | BUY | 161 @ USD 44.06 | USD 7,094 | The ETF bought 161 new shares of SRRK (Scholar Rock Holding Corp). The shares were bought for an average price of 44.06 compared to the previous average buy price of 35.5021. This is 24.1% higher than average price of previous purchases of SRRK. |
| ACAD - ACADIA Pharmaceuticals Inc | BUY | 283 @ USD 25.04 | USD 7,086 | The ETF bought 283 new shares of ACAD (ACADIA Pharmaceuticals Inc). The shares were bought for an average price of 25.04 compared to the previous average buy price of 21.18. This is 18.2% higher than average price of previous purchases of ACAD. |
| IMVT - Immunovant Inc | BUY | 293 @ USD 24.15 | USD 7,076 | The ETF bought 293 new shares of IMVT (Immunovant Inc). The shares were bought for an average price of 24.15 compared to the previous average buy price of 18.485. This is 30.6% higher than average price of previous purchases of IMVT. |
| PRAX - Praxis Precision Medicines Inc | BUY | 35 @ USD 196.46 | USD 6,876 | The ETF bought 35 new shares of PRAX (Praxis Precision Medicines Inc). The shares were bought for an average price of 196.46 compared to the previous average buy price of 73.9258. This is 165.8% higher than average price of previous purchases of PRAX. |
| LGND - Ligand Pharmaceuticals Incorporated | BUY | 33 @ USD 203.18 | USD 6,705 | The ETF bought 33 new shares of LGND (Ligand Pharmaceuticals Incorporated). The shares were bought for an average price of 203.18 compared to the previous average buy price of 139.821. This is 45.3% higher than average price of previous purchases of LGND. |
| ACLX - Arcellx Inc | BUY | 92 @ USD 72.71 | USD 6,689 | The ETF bought 92 new shares of ACLX (Arcellx Inc). The shares were bought for an average price of 72.71 compared to the previous average buy price of 72.9036. This is -0.3% lower than average price of previous purchases of ACLX. |
| GRAL - GRAIL, LLC | BUY | 60 @ USD 110.39 | USD 6,623 | The ETF bought 60 new shares of GRAL (GRAIL, LLC). The shares were bought for an average price of 110.39 compared to the previous average buy price of 56.294. This is 96.1% higher than average price of previous purchases of GRAL. |
| AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock | BUY | 528 @ USD 12.52 | USD 6,611 | The ETF bought 528 new shares of AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock). The shares were bought for an average price of 12.52 compared to the previous average buy price of 9.11659. This is 37.3% higher than average price of previous purchases of AMRX. |
| VCYT - Veracyte Inc | BUY | 132 @ USD 47.34 | USD 6,249 | The ETF bought 132 new shares of VCYT (Veracyte Inc). The shares were bought for an average price of 47.34 compared to the previous average buy price of 32.3836. This is 46.2% higher than average price of previous purchases of VCYT. |
| MIRM - Mirum Pharmaceuticals Inc | BUY | 84 @ USD 73.05 | USD 6,136 | The ETF bought 84 new shares of MIRM (Mirum Pharmaceuticals Inc). The shares were bought for an average price of 73.05 compared to the previous average buy price of 57.0019. This is 28.2% higher than average price of previous purchases of MIRM. |
| ARQT - Arcutis Biotherapeutics Inc | BUY | 198 @ USD 30.65 | USD 6,069 | The ETF bought 198 new shares of ARQT (Arcutis Biotherapeutics Inc). The shares were bought for an average price of 30.65 compared to the previous average buy price of 17.4254. This is 75.9% higher than average price of previous purchases of ARQT. |
| XENE - Xenon Pharmaceuticals Inc | BUY | 129 @ USD 44.72 | USD 5,769 | The ETF bought 129 new shares of XENE (Xenon Pharmaceuticals Inc). The shares were bought for an average price of 44.72 compared to the previous average buy price of 36.1706. This is 23.6% higher than average price of previous purchases of XENE. |
| CGON - CG Oncology, Inc. Common stock | BUY | 128 @ USD 44.84 | USD 5,740 | The ETF bought 128 new shares of CGON (CG Oncology, Inc. Common stock). The shares were bought for an average price of 44.84 compared to the previous average buy price of 31.0802. This is 44.3% higher than average price of previous purchases of CGON. |
| TARS - Tarsus Pharmaceuticals Inc | BUY | 71 @ USD 79.96 | USD 5,677 | The ETF bought 71 new shares of TARS (Tarsus Pharmaceuticals Inc). The shares were bought for an average price of 79.96 compared to the previous average buy price of 51.6617. This is 54.8% higher than average price of previous purchases of TARS. |
| RARE - Ultragenyx | BUY | 162 @ USD 34.75 | USD 5,630 | The ETF bought 162 new shares of RARE (Ultragenyx). The shares were bought for an average price of 34.75 compared to the previous average buy price of 35.9796. This is -3.4% lower than average price of previous purchases of RARE. |
| RARE - WISETFWTMRARETFP | BUY | 162 @ USD 34.75 | USD 5,630 | The ETF bought 162 new shares of RARE (WISETFWTMRARETFP). The shares were bought for an average price of 34.75 compared to the previous average buy price of 35.9796. This is -3.4% lower than average price of previous purchases of RARE. |
| APGE - Apogee Therapeutics, Inc. Common Stock | BUY | 76 @ USD 71.97 | USD 5,470 | The ETF bought 76 new shares of APGE (Apogee Therapeutics, Inc. Common Stock). The shares were bought for an average price of 71.97 compared to the previous average buy price of 46.0092. This is 56.4% higher than average price of previous purchases of APGE. |
| IRON - Ironveld Plc | BUY | 58 @ USD 93.36 | USD 5,415 | The ETF bought 58 new shares of IRON (Ironveld Plc). The shares were bought for an average price of 93.36 compared to the previous average buy price of 61.4919. This is 51.8% higher than average price of previous purchases of IRON. |
| IDYA - Ideaya Biosciences Inc | BUY | 148 @ USD 35.62 | USD 5,272 | The ETF bought 148 new shares of IDYA (Ideaya Biosciences Inc). The shares were bought for an average price of 35.62 compared to the previous average buy price of 24.3942. This is 46.0% higher than average price of previous purchases of IDYA. |
| DYN - Dyne Therapeutics Inc | BUY | 239 @ USD 21.9 | USD 5,234 | The ETF bought 239 new shares of DYN (Dyne Therapeutics Inc). The shares were bought for an average price of 21.9 compared to the previous average buy price of 13.4448. This is 62.9% higher than average price of previous purchases of DYN. |
| DYN - DYNAGREEN EN.PR.GR.H YC 1 | BUY | 239 @ USD 21.9 | USD 5,234 | The ETF bought 239 new shares of DYN (DYNAGREEN EN.PR.GR.H YC 1). The shares were bought for an average price of 21.9 compared to the previous average buy price of 13.4448. This is 62.9% higher than average price of previous purchases of DYN. |
| TVTX - Travere Therapeutics Inc | BUY | 147 @ USD 35.41 | USD 5,205 | The ETF bought 147 new shares of TVTX (Travere Therapeutics Inc). The shares were bought for an average price of 35.41 compared to the previous average buy price of 21.2616. This is 66.5% higher than average price of previous purchases of TVTX. |
| FOLD - Amicus Therapeutics Inc | BUY | 510 @ USD 9.93 | USD 5,064 | The ETF bought 510 new shares of FOLD (Amicus Therapeutics Inc). The shares were bought for an average price of 9.93 compared to the previous average buy price of 7.57859. This is 31.0% higher than average price of previous purchases of FOLD. |
| ADPT - Adaptive Biotechnologies Corp | BUY | 252 @ USD 19.66 | USD 4,954 | The ETF bought 252 new shares of ADPT (Adaptive Biotechnologies Corp). The shares were bought for an average price of 19.66 compared to the previous average buy price of 12.3604. This is 59.1% higher than average price of previous purchases of ADPT. |
| DNLI - Denali Therapeutics Inc | BUY | 242 @ USD 19.47 | USD 4,712 | The ETF bought 242 new shares of DNLI (Denali Therapeutics Inc). The shares were bought for an average price of 19.47 compared to the previous average buy price of 15.4394. This is 26.1% higher than average price of previous purchases of DNLI. |
| MLYS - Mineralys Therapeutics, Inc. Common Stock | BUY | 109 @ USD 43.12 | USD 4,700 | The ETF bought 109 new shares of MLYS (Mineralys Therapeutics, Inc. Common Stock). The shares were bought for an average price of 43.12 compared to the previous average buy price of 21.4544. This is 101.0% higher than average price of previous purchases of MLYS. |
| CNTA - Centessa Pharmaceuticals PLC ADR | BUY | 158 @ USD 29.03 | USD 4,587 | The ETF bought 158 new shares of CNTA (Centessa Pharmaceuticals PLC ADR). The shares were bought for an average price of 29.03 compared to the previous average buy price of 17.4527. This is 66.3% higher than average price of previous purchases of CNTA. |
| EWTX - Edgewise Therapeutics Inc | BUY | 174 @ USD 26.04 | USD 4,531 | The ETF bought 174 new shares of EWTX (Edgewise Therapeutics Inc). The shares were bought for an average price of 26.04 compared to the previous average buy price of 16.5157. This is 57.7% higher than average price of previous purchases of EWTX. |
| APLS - Apellis Pharmaceuticals Inc | BUY | 212 @ USD 21.3 | USD 4,516 | The ETF bought 212 new shares of APLS (Apellis Pharmaceuticals Inc). The shares were bought for an average price of 21.3 compared to the previous average buy price of 20.9406. This is 1.7% higher than average price of previous purchases of APLS. |
| SUPN - Supernus Pharmaceuticals Inc | BUY | 94 @ USD 45.59 | USD 4,285 | The ETF bought 94 new shares of SUPN (Supernus Pharmaceuticals Inc). The shares were bought for an average price of 45.59 compared to the previous average buy price of 38.1839. This is 19.4% higher than average price of previous purchases of SUPN. |
| BEAM - Beam Therapeutics Inc | BUY | 167 @ USD 25.33 | USD 4,230 | The ETF bought 167 new shares of BEAM (Beam Therapeutics Inc). The shares were bought for an average price of 25.33 compared to the previous average buy price of 20.8125. This is 21.7% higher than average price of previous purchases of BEAM. |
| TERN - Tern Plc | BUY | 145 @ USD 28.11 | USD 4,076 | The ETF bought 145 new shares of TERN (Tern Plc). The shares were bought for an average price of 28.11 compared to the previous average buy price of 7.24803. This is 287.8% higher than average price of previous purchases of TERN. |
| LEGN - Legend Biotech Corp | BUY | 140 @ USD 27.71 | USD 3,879 | The ETF bought 140 new shares of LEGN (Legend Biotech Corp). The shares were bought for an average price of 27.71 compared to the previous average buy price of 34.1405. This is -18.8% lower than average price of previous purchases of LEGN. |
| IBRX - Immunitybio Inc | BUY | 1,591 @ USD 2.36 | USD 3,755 | The ETF bought 1591 new shares of IBRX (Immunitybio Inc). The shares were bought for an average price of 2.36 compared to the previous average buy price of 2.70547. This is -12.8% lower than average price of previous purchases of IBRX. |
| TXG - 10X Genomics Inc | BUY | 191 @ USD 18.81 | USD 3,593 | The ETF bought 191 new shares of TXG (10X Genomics Inc). The shares were bought for an average price of 18.81 compared to the previous average buy price of 12.6488. This is 48.7% higher than average price of previous purchases of TXG. |
| TXG - Terex Corporation | BUY | 191 @ USD 18.81 | USD 3,593 | The ETF bought 191 new shares of TXG (Terex Corporation). The shares were bought for an average price of 18.81 compared to the previous average buy price of 12.6488. This is 48.7% higher than average price of previous purchases of TXG. |
| VERA - Vera Therapeutics Inc | BUY | 105 @ USD 33.75 | USD 3,544 | The ETF bought 105 new shares of VERA (Vera Therapeutics Inc). The shares were bought for an average price of 33.75 compared to the previous average buy price of 27.0717. This is 24.7% higher than average price of previous purchases of VERA. |
| AUPH - Aurinia Pharmaceuticals Inc | BUY | 218 @ USD 16.12 | USD 3,514 | The ETF bought 218 new shares of AUPH (Aurinia Pharmaceuticals Inc). The shares were bought for an average price of 16.12 compared to the previous average buy price of 9.84525. This is 63.7% higher than average price of previous purchases of AUPH. |
| GPCR - Structure Therapeutics Inc. American Depositary Shares | BUY | 98 @ USD 35.81 | USD 3,509 | The ETF bought 98 new shares of GPCR (Structure Therapeutics Inc. American Depositary Shares). The shares were bought for an average price of 35.81 compared to the previous average buy price of 24.2076. This is 47.9% higher than average price of previous purchases of GPCR. |
| OCUL - Ocular Therapeutix Inc | BUY | 288 @ USD 12.15 | USD 3,499 | The ETF bought 288 new shares of OCUL (Ocular Therapeutix Inc). The shares were bought for an average price of 12.15 compared to the previous average buy price of 10.1687. This is 19.5% higher than average price of previous purchases of OCUL. |
| AVDL - Avadel Pharmaceuticals PLC | BUY | 161 @ USD 21.49 | USD 3,460 | The ETF bought 161 new shares of AVDL (Avadel Pharmaceuticals PLC). The shares were bought for an average price of 21.49 compared to the previous average buy price of 12.0642. This is 78.1% higher than average price of previous purchases of AVDL. |
| SRPT - Sarepta Therapeutics Inc | BUY | 162 @ USD 21.34 | USD 3,457 | The ETF bought 162 new shares of SRPT (Sarepta Therapeutics Inc). The shares were bought for an average price of 21.34 compared to the previous average buy price of 32.505. This is -34.3% lower than average price of previous purchases of SRPT. |
| ZYME - Zymeworks Inc. Common Stock | BUY | 128 @ USD 26.71 | USD 3,419 | The ETF bought 128 new shares of ZYME (Zymeworks Inc. Common Stock). The shares were bought for an average price of 26.71 compared to the previous average buy price of 15.3887. This is 73.6% higher than average price of previous purchases of ZYME. |
| JANX - Janux Therapeutics Inc | BUY | 99 @ USD 34.09 | USD 3,375 | The ETF bought 99 new shares of JANX (Janux Therapeutics Inc). The shares were bought for an average price of 34.09 compared to the previous average buy price of 28.0144. This is 21.7% higher than average price of previous purchases of JANX. |
| HRMY - Harmony Biosciences Holdings | BUY | 95 @ USD 35.29 | USD 3,353 | The ETF bought 95 new shares of HRMY (Harmony Biosciences Holdings). The shares were bought for an average price of 35.29 compared to the previous average buy price of 32.1335. This is 9.8% higher than average price of previous purchases of HRMY. |
| RXRX - Recursion Pharmaceuticals Inc | BUY | 722 @ USD 4.63 | USD 3,343 | The ETF bought 722 new shares of RXRX (Recursion Pharmaceuticals Inc). The shares were bought for an average price of 4.63 compared to the previous average buy price of 5.66681. This is -18.3% lower than average price of previous purchases of RXRX. |
| VCEL - Vericel Corp Ord | BUY | 83 @ USD 40.25 | USD 3,341 | The ETF bought 83 new shares of VCEL (Vericel Corp Ord). The shares were bought for an average price of 40.25 compared to the previous average buy price of 40.7134. This is -1.1% lower than average price of previous purchases of VCEL. |
| TWST - Twist Bioscience Corp | BUY | 100 @ USD 32.01 | USD 3,201 | The ETF bought 100 new shares of TWST (Twist Bioscience Corp). The shares were bought for an average price of 32.01 compared to the previous average buy price of 35.5826. This is -10.0% lower than average price of previous purchases of TWST. |
| OLMA - Olema Pharmaceuticals Inc | BUY | 112 @ USD 28.32 | USD 3,172 | The ETF bought 112 new shares of OLMA (Olema Pharmaceuticals Inc). The shares were bought for an average price of 28.32 compared to the previous average buy price of 6.85346. This is 313.2% higher than average price of previous purchases of OLMA. |
| KNSA - Kiniksa Pharmaceuticals Ltd | BUY | 73 @ USD 42.52 | USD 3,104 | The ETF bought 73 new shares of KNSA (Kiniksa Pharmaceuticals Ltd). The shares were bought for an average price of 42.52 compared to the previous average buy price of 30.9748. This is 37.3% higher than average price of previous purchases of KNSA. |
| ANIP - ANI Pharmaceuticals Inc | BUY | 36 @ USD 84.85 | USD 3,055 | The ETF bought 36 new shares of ANIP (ANI Pharmaceuticals Inc). The shares were bought for an average price of 84.85 compared to the previous average buy price of 72.7138. This is 16.7% higher than average price of previous purchases of ANIP. |
| SYRE - Spyre Therapeutics Inc. | BUY | 99 @ USD 30 | USD 2,970 | The ETF bought 99 new shares of SYRE (Spyre Therapeutics Inc.). The shares were bought for an average price of 30 compared to the previous average buy price of 18.3688. This is 63.3% higher than average price of previous purchases of SYRE. |
| STOK - Stoke Therapeutics Inc | BUY | 93 @ USD 30.91 | USD 2,875 | The ETF bought 93 new shares of STOK (Stoke Therapeutics Inc). The shares were bought for an average price of 30.91 compared to the previous average buy price of 17.0884. This is 80.9% higher than average price of previous purchases of STOK. |
| SNDX - Syndax Pharmaceuticals Inc | BUY | 143 @ USD 19.82 | USD 2,834 | The ETF bought 143 new shares of SNDX (Syndax Pharmaceuticals Inc). The shares were bought for an average price of 19.82 compared to the previous average buy price of 12.2987. This is 61.2% higher than average price of previous purchases of SNDX. |
| AGIO - Agios Pharm | BUY | 96 @ USD 29.2 | USD 2,803 | The ETF bought 96 new shares of AGIO (Agios Pharm). The shares were bought for an average price of 29.2 compared to the previous average buy price of 35.9917. This is -18.9% lower than average price of previous purchases of AGIO. |
| MNKD - MannKind Corp | BUY | 510 @ USD 5.35 | USD 2,729 | The ETF bought 510 new shares of MNKD (MannKind Corp). The shares were bought for an average price of 5.35 compared to the previous average buy price of 4.75758. This is 12.5% higher than average price of previous purchases of MNKD. |
| IMCR - Immunocore Holdings Ltd | BUY | 68 @ USD 39.5 | USD 2,686 | The ETF bought 68 new shares of IMCR (Immunocore Holdings Ltd). The shares were bought for an average price of 39.5 compared to the previous average buy price of 33.3617. This is 18.4% higher than average price of previous purchases of IMCR. |
| HROW - Harrow Health Inc | BUY | 61 @ USD 41.78 | USD 2,549 | The ETF bought 61 new shares of HROW (Harrow Health Inc). The shares were bought for an average price of 41.78 compared to the previous average buy price of 34.0273. This is 22.8% higher than average price of previous purchases of HROW. |
| QURE - Uniqure NV | BUY | 92 @ USD 27.51 | USD 2,531 | The ETF bought 92 new shares of QURE (Uniqure NV). The shares were bought for an average price of 27.51 compared to the previous average buy price of 23.4213. This is 17.5% higher than average price of previous purchases of QURE. |
| BCRX - BioCryst Pharmaceuticals Inc | BUY | 349 @ USD 7.18 | USD 2,506 | The ETF bought 349 new shares of BCRX (BioCryst Pharmaceuticals Inc). The shares were bought for an average price of 7.18 compared to the previous average buy price of 8.17782. This is -12.2% lower than average price of previous purchases of BCRX. |
| COLL - Collegium Pharmaceutical Inc | BUY | 52 @ USD 46.68 | USD 2,427 | The ETF bought 52 new shares of COLL (Collegium Pharmaceutical Inc). The shares were bought for an average price of 46.68 compared to the previous average buy price of 33.0234. This is 41.4% higher than average price of previous purchases of COLL. |
| NVCR - Novocure Ltd | BUY | 186 @ USD 12.81 | USD 2,383 | The ETF bought 186 new shares of NVCR (Novocure Ltd). The shares were bought for an average price of 12.81 compared to the previous average buy price of 16.2317. This is -21.1% lower than average price of previous purchases of NVCR. |
| NRIX - Nurix Therapeutics Inc | BUY | 134 @ USD 17.68 | USD 2,369 | The ETF bought 134 new shares of NRIX (Nurix Therapeutics Inc). The shares were bought for an average price of 17.68 compared to the previous average buy price of 12.3365. This is 43.3% higher than average price of previous purchases of NRIX. |
| ARDX - Ardelyx Inc | BUY | 401 @ USD 5.8 | USD 2,326 | The ETF bought 401 new shares of ARDX (Ardelyx Inc). The shares were bought for an average price of 5.8 compared to the previous average buy price of 4.73646. This is 22.5% higher than average price of previous purchases of ARDX. |
| URGN - UroGen Pharma Ltd | BUY | 79 @ USD 28.81 | USD 2,276 | The ETF bought 79 new shares of URGN (UroGen Pharma Ltd). The shares were bought for an average price of 28.81 compared to the previous average buy price of 15.6796. This is 83.7% higher than average price of previous purchases of URGN. |
| RLAY - Relay Therapeutics Inc | BUY | 287 @ USD 7.92 | USD 2,273 | The ETF bought 287 new shares of RLAY (Relay Therapeutics Inc). The shares were bought for an average price of 7.92 compared to the previous average buy price of 4.39537. This is 80.2% higher than average price of previous purchases of RLAY. |
| INVA - Innoviva Inc | BUY | 104 @ USD 21.73 | USD 2,260 | The ETF bought 104 new shares of INVA (Innoviva Inc). The shares were bought for an average price of 21.73 compared to the previous average buy price of 19.1944. This is 13.2% higher than average price of previous purchases of INVA. |
| GMAB - Genmab AS | BUY | 69 @ USD 32.36 | USD 2,233 | The ETF bought 69 new shares of GMAB (Genmab AS). The shares were bought for an average price of 32.36 compared to the previous average buy price of 24.1267. This is 34.1% higher than average price of previous purchases of GMAB. |
| DVAX - Dynavax Technologies Corporation | BUY | 195 @ USD 11.37 | USD 2,217 | The ETF bought 195 new shares of DVAX (Dynavax Technologies Corporation). The shares were bought for an average price of 11.37 compared to the previous average buy price of 10.5808. This is 7.5% higher than average price of previous purchases of DVAX. |
| AMLX - Amylyx Pharmaceuticals Inc | BUY | 148 @ USD 14.98 | USD 2,217 | The ETF bought 148 new shares of AMLX (Amylyx Pharmaceuticals Inc). The shares were bought for an average price of 14.98 compared to the previous average buy price of 7.47651. This is 100.4% higher than average price of previous purchases of AMLX. |
| TSHA - Taysha Gene Therapies Inc | BUY | 455 @ USD 4.74 | USD 2,157 | The ETF bought 455 new shares of TSHA (Taysha Gene Therapies Inc). The shares were bought for an average price of 4.74 compared to the previous average buy price of 2.99711. This is 58.2% higher than average price of previous purchases of TSHA. |
| AMPH - Amphastar P | BUY | 77 @ USD 27.7 | USD 2,133 | The ETF bought 77 new shares of AMPH (Amphastar P). The shares were bought for an average price of 27.7 compared to the previous average buy price of 25.5854. This is 8.3% higher than average price of previous purchases of AMPH. |
| ELVN - Enliven Therapeutics Inc. | BUY | 98 @ USD 21.6 | USD 2,117 | The ETF bought 98 new shares of ELVN (Enliven Therapeutics Inc.). The shares were bought for an average price of 21.6 compared to the previous average buy price of 20.5187. This is 5.3% higher than average price of previous purchases of ELVN. |
| WVE - Wave Life Sciences Ltd | BUY | 272 @ USD 7.76 | USD 2,111 | The ETF bought 272 new shares of WVE (Wave Life Sciences Ltd). The shares were bought for an average price of 7.76 compared to the previous average buy price of 8.33467. This is -6.9% lower than average price of previous purchases of WVE. |
| CVAC - CureVac NV | BUY | 376 @ USD 5.49 | USD 2,064 | The ETF bought 376 new shares of CVAC (CureVac NV). The shares were bought for an average price of 5.49 compared to the previous average buy price of 4.88628. This is 12.4% higher than average price of previous purchases of CVAC. |
| XNCR - Xencor Inc | BUY | 119 @ USD 17.32 | USD 2,061 | The ETF bought 119 new shares of XNCR (Xencor Inc). The shares were bought for an average price of 17.32 compared to the previous average buy price of 11.6001. This is 49.3% higher than average price of previous purchases of XNCR. |
| TNGX - Tango Therapeutics Inc | BUY | 185 @ USD 10.91 | USD 2,018 | The ETF bought 185 new shares of TNGX (Tango Therapeutics Inc). The shares were bought for an average price of 10.91 compared to the previous average buy price of 6.55433. This is 66.5% higher than average price of previous purchases of TNGX. |
| XERS - Xeris Pharmaceuticals Inc | BUY | 278 @ USD 7.18 | USD 1,996 | The ETF bought 278 new shares of XERS (Xeris Pharmaceuticals Inc). The shares were bought for an average price of 7.18 compared to the previous average buy price of 6.14203. This is 16.9% higher than average price of previous purchases of XERS. |
| PGEN - Precigen Inc | BUY | 509 @ USD 3.83 | USD 1,949 | The ETF bought 509 new shares of PGEN (Precigen Inc). The shares were bought for an average price of 3.83 compared to the previous average buy price of 2.47921. This is 54.5% higher than average price of previous purchases of PGEN. |
| ORIC - Oric Pharmaceuticals Inc | BUY | 162 @ USD 11.88 | USD 1,925 | The ETF bought 162 new shares of ORIC (Oric Pharmaceuticals Inc). The shares were bought for an average price of 11.88 compared to the previous average buy price of 10.5982. This is 12.1% higher than average price of previous purchases of ORIC. |
| FTRE - Fortrea Holdings Inc. | BUY | 151 @ USD 12.71 | USD 1,919 | The ETF bought 151 new shares of FTRE (Fortrea Holdings Inc.). The shares were bought for an average price of 12.71 compared to the previous average buy price of 7.11313. This is 78.7% higher than average price of previous purchases of FTRE. |
| CSTL - Castle Biosciences Inc | BUY | 48 @ USD 39.95 | USD 1,918 | The ETF bought 48 new shares of CSTL (Castle Biosciences Inc). The shares were bought for an average price of 39.95 compared to the previous average buy price of 23.1925. This is 72.3% higher than average price of previous purchases of CSTL. |
| ANAB - AnaptysBio Inc | BUY | 46 @ USD 41.65 | USD 1,916 | The ETF bought 46 new shares of ANAB (AnaptysBio Inc). The shares were bought for an average price of 41.65 compared to the previous average buy price of 25.5262. This is 63.2% higher than average price of previous purchases of ANAB. |
| NVAX - Novavax Inc | BUY | 271 @ USD 7.05 | USD 1,911 | The ETF bought 271 new shares of NVAX (Novavax Inc). The shares were bought for an average price of 7.05 compared to the previous average buy price of 7.30729. This is -3.5% lower than average price of previous purchases of NVAX. |
| NVAX - Hana Microelectronics Public Company Limited | BUY | 271 @ USD 7.05 | USD 1,911 | The ETF bought 271 new shares of NVAX (Hana Microelectronics Public Company Limited). The shares were bought for an average price of 7.05 compared to the previous average buy price of 7.30729. This is -3.5% lower than average price of previous purchases of NVAX. |
| PHAT - Phathom Pharmaceuticals Inc | BUY | 121 @ USD 15.62 | USD 1,890 | The ETF bought 121 new shares of PHAT (Phathom Pharmaceuticals Inc). The shares were bought for an average price of 15.62 compared to the previous average buy price of 9.57937. This is 63.1% higher than average price of previous purchases of PHAT. |
| SANA - Sana Biotechnology Inc | BUY | 439 @ USD 4.3 | USD 1,888 | The ETF bought 439 new shares of SANA (Sana Biotechnology Inc). The shares were bought for an average price of 4.3 compared to the previous average buy price of 3.25775. This is 32.0% higher than average price of previous purchases of SANA. |
| ABCL - Abcellera Biologics Inc | BUY | 500 @ USD 3.73 | USD 1,865 | The ETF bought 500 new shares of ABCL (Abcellera Biologics Inc). The shares were bought for an average price of 3.73 compared to the previous average buy price of 3.89641. This is -4.3% lower than average price of previous purchases of ABCL. |
| KURA - Kura Oncology Inc | BUY | 151 @ USD 12.14 | USD 1,833 | The ETF bought 151 new shares of KURA (Kura Oncology Inc). The shares were bought for an average price of 12.14 compared to the previous average buy price of 7.61862. This is 59.3% higher than average price of previous purchases of KURA. |
| SVRA - Savara Inc | BUY | 288 @ USD 6.29 | USD 1,812 | The ETF bought 288 new shares of SVRA (Savara Inc). The shares were bought for an average price of 6.29 compared to the previous average buy price of 3.03658. This is 107.1% higher than average price of previous purchases of SVRA. |
| GRFS - Grifols SA ADR | BUY | 204 @ USD 8.84999 | USD 1,805 | The ETF bought 204 new shares of GRFS (Grifols SA ADR). The shares were bought for an average price of 8.84999 compared to the previous average buy price of 9.33781. This is -5.2% lower than average price of previous purchases of GRFS. |
| PCRX - Pacira BioSciences, Inc. | BUY | 75 @ USD 23.57 | USD 1,768 | The ETF bought 75 new shares of PCRX (Pacira BioSciences, Inc.). The shares were bought for an average price of 23.57 compared to the previous average buy price of 23.7801. This is -0.9% lower than average price of previous purchases of PCRX. |
| EYPT - Eyepoint Pharmaceuticals Inc | BUY | 115 @ USD 14.83 | USD 1,705 | The ETF bought 115 new shares of EYPT (Eyepoint Pharmaceuticals Inc). The shares were bought for an average price of 14.83 compared to the previous average buy price of 9.19439. This is 61.3% higher than average price of previous purchases of EYPT. |
| TBPH - Theravance Biopharma Inc | BUY | 84 @ USD 20.3 | USD 1,705 | The ETF bought 84 new shares of TBPH (Theravance Biopharma Inc). The shares were bought for an average price of 20.3 compared to the previous average buy price of 12.4353. This is 63.2% higher than average price of previous purchases of TBPH. |
| MNMD - Mind Medicine Inc | BUY | 130 @ USD 12.65 | USD 1,645 | The ETF bought 130 new shares of MNMD (Mind Medicine Inc). The shares were bought for an average price of 12.65 compared to the previous average buy price of 8.89592. This is 42.2% higher than average price of previous purchases of MNMD. |
| NTLA - Intellia Therapeutics Inc | BUY | 182 @ USD 8.99 | USD 1,636 | The ETF bought 182 new shares of NTLA (Intellia Therapeutics Inc). The shares were bought for an average price of 8.99 compared to the previous average buy price of 12.0577. This is -25.4% lower than average price of previous purchases of NTLA. |
| ZLAB - Zai Lab Ltd | BUY | 80 @ USD 20.41 | USD 1,633 | The ETF bought 80 new shares of ZLAB (Zai Lab Ltd). The shares were bought for an average price of 20.41 compared to the previous average buy price of 33.0089. This is -38.2% lower than average price of previous purchases of ZLAB. |
| ERAS - Erasca Inc | BUY | 509 @ USD 3.17 | USD 1,614 | The ETF bought 509 new shares of ERAS (Erasca Inc). The shares were bought for an average price of 3.17 compared to the previous average buy price of 1.78343. This is 77.7% higher than average price of previous purchases of ERAS. |
| DAWN - Day One Biopharmaceuticals Inc | BUY | 170 @ USD 9.49 | USD 1,613 | The ETF bought 170 new shares of DAWN (Day One Biopharmaceuticals Inc). The shares were bought for an average price of 9.49 compared to the previous average buy price of 7.57523. This is 25.3% higher than average price of previous purchases of DAWN. |
| SPRY - Silverback Therapeutics Inc | BUY | 164 @ USD 9.54001 | USD 1,565 | The ETF bought 164 new shares of SPRY (Silverback Therapeutics Inc). The shares were bought for an average price of 9.54001 compared to the previous average buy price of 13.21. This is -27.8% lower than average price of previous purchases of SPRY. |
| ARVN - Arvinas Inc | BUY | 120 @ USD 12.585 | USD 1,510 | The ETF bought 120 new shares of ARVN (Arvinas Inc). The shares were bought for an average price of 12.585 compared to the previous average buy price of 9.05145. This is 39.0% higher than average price of previous purchases of ARVN. |
| VIR - Vir Biotechnology Inc | BUY | 231 @ USD 6.42 | USD 1,483 | The ETF bought 231 new shares of VIR (Vir Biotechnology Inc). The shares were bought for an average price of 6.42 compared to the previous average buy price of 5.8425. This is 9.9% higher than average price of previous purchases of VIR. |
| VIR - Vidrala S.A | BUY | 231 @ USD 6.42 | USD 1,483 | The ETF bought 231 new shares of VIR (Vidrala S.A). The shares were bought for an average price of 6.42 compared to the previous average buy price of 5.8425. This is 9.9% higher than average price of previous purchases of VIR. |
| IOVA - Iovance Biotherapeutics Inc | BUY | 596 @ USD 2.47 | USD 1,472 | The ETF bought 596 new shares of IOVA (Iovance Biotherapeutics Inc). The shares were bought for an average price of 2.47 compared to the previous average buy price of 2.43792. This is 1.3% higher than average price of previous purchases of IOVA. |
| ABUS - Arbutus Biopharma Corp | BUY | 328 @ USD 4.41 | USD 1,446 | The ETF bought 328 new shares of ABUS (Arbutus Biopharma Corp). The shares were bought for an average price of 4.41 compared to the previous average buy price of 3.7136. This is 18.8% higher than average price of previous purchases of ABUS. |
| PAHC - Phibro Animal Health Corporation | BUY | 33 @ USD 41.88 | USD 1,382 | The ETF bought 33 new shares of PAHC (Phibro Animal Health Corporation). The shares were bought for an average price of 41.88 compared to the previous average buy price of 29.8197. This is 40.4% higher than average price of previous purchases of PAHC. |
| REPL - Replimune Group Inc | BUY | 134 @ USD 10 | USD 1,340 | The ETF bought 134 new shares of REPL (Replimune Group Inc). The shares were bought for an average price of 10 compared to the previous average buy price of 8.90194. This is 12.3% higher than average price of previous purchases of REPL. |
| GERN - Geron Corporation | BUY | 1,064 @ USD 1.18 | USD 1,256 | The ETF bought 1064 new shares of GERN (Geron Corporation). The shares were bought for an average price of 1.18 compared to the previous average buy price of 1.4743. This is -20.0% lower than average price of previous purchases of GERN. |
| PACB - Pacific Biosciences of California | BUY | 534 @ USD 2.32 | USD 1,239 | The ETF bought 534 new shares of PACB (Pacific Biosciences of California). The shares were bought for an average price of 2.32 compared to the previous average buy price of 1.58278. This is 46.6% higher than average price of previous purchases of PACB. |
| KALV - Kalvista Pharmaceuticals Inc | BUY | 82 @ USD 14.47 | USD 1,187 | The ETF bought 82 new shares of KALV (Kalvista Pharmaceuticals Inc). The shares were bought for an average price of 14.47 compared to the previous average buy price of 12.5057. This is 15.7% higher than average price of previous purchases of KALV. |
| RGNX - Regenxbio Inc | BUY | 88 @ USD 13.39 | USD 1,178 | The ETF bought 88 new shares of RGNX (Regenxbio Inc). The shares were bought for an average price of 13.39 compared to the previous average buy price of 9.45114. This is 41.7% higher than average price of previous purchases of RGNX. |
| KROS - Keros Therapeutics Inc | BUY | 67 @ USD 17.48 | USD 1,171 | The ETF bought 67 new shares of KROS (Keros Therapeutics Inc). The shares were bought for an average price of 17.48 compared to the previous average buy price of 14.1005. This is 24.0% higher than average price of previous purchases of KROS. |
| CGEM - Cullinan Oncology LLC | BUY | 103 @ USD 11.37 | USD 1,171 | The ETF bought 103 new shares of CGEM (Cullinan Oncology LLC). The shares were bought for an average price of 11.37 compared to the previous average buy price of 8.11046. This is 40.2% higher than average price of previous purchases of CGEM. |
| MGTX - MeiraGTx Holdings PLC | BUY | 136 @ USD 8.3 | USD 1,129 | The ETF bought 136 new shares of MGTX (MeiraGTx Holdings PLC). The shares were bought for an average price of 8.3 compared to the previous average buy price of 7.27084. This is 14.2% higher than average price of previous purchases of MGTX. |
| PRME - Prime Medicine, Inc. Common Stock | BUY | 295 @ USD 3.82 | USD 1,127 | The ETF bought 295 new shares of PRME (Prime Medicine, Inc. Common Stock). The shares were bought for an average price of 3.82 compared to the previous average buy price of 4.47313. This is -14.6% lower than average price of previous purchases of PRME. |
| PRTA - Prothena Corporation plc | BUY | 93 @ USD 10.75 | USD 1,000 | The ETF bought 93 new shares of PRTA (Prothena Corporation plc). The shares were bought for an average price of 10.75 compared to the previous average buy price of 9.13781. This is 17.6% higher than average price of previous purchases of PRTA. |
| FDMT - 4D Molecular Therapeutics Inc | BUY | 85 @ USD 11.66 | USD 991 | The ETF bought 85 new shares of FDMT (4D Molecular Therapeutics Inc). The shares were bought for an average price of 11.66 compared to the previous average buy price of 6.85048. This is 70.2% higher than average price of previous purchases of FDMT. |
| MRVI - Maravai Lifesciences Holdings Inc | BUY | 265 @ USD 3.62 | USD 959 | The ETF bought 265 new shares of MRVI (Maravai Lifesciences Holdings Inc). The shares were bought for an average price of 3.62 compared to the previous average buy price of 2.79452. This is 29.5% higher than average price of previous purchases of MRVI. |
| LXRX - Lexicon Pharmaceuticals Inc | BUY | 642 @ USD 1.43 | USD 918 | The ETF bought 642 new shares of LXRX (Lexicon Pharmaceuticals Inc). The shares were bought for an average price of 1.43 compared to the previous average buy price of 1.09672. This is 30.4% higher than average price of previous purchases of LXRX. |
| IRWD - Ironwood Pharmaceuticals Inc | BUY | 259 @ USD 3.5 | USD 907 | The ETF bought 259 new shares of IRWD (Ironwood Pharmaceuticals Inc). The shares were bought for an average price of 3.5 compared to the previous average buy price of 1.42457. This is 145.7% higher than average price of previous purchases of IRWD. |
| EOLS - Evolus Inc | BUY | 119 @ USD 7.16 | USD 852 | The ETF bought 119 new shares of EOLS (Evolus Inc). The shares were bought for an average price of 7.16 compared to the previous average buy price of 8.97813. This is -20.3% lower than average price of previous purchases of EOLS. |
| GLPG - Galapagos NV ADR | BUY | 25 @ USD 31.32 | USD 783 | The ETF bought 25 new shares of GLPG (Galapagos NV ADR). The shares were bought for an average price of 31.32 compared to the previous average buy price of 29.328. This is 6.8% higher than average price of previous purchases of GLPG. |
| GLPG - Galapagos N.V. | BUY | 25 @ USD 31.32 | USD 783 | The ETF bought 25 new shares of GLPG (Galapagos N.V.). The shares were bought for an average price of 31.32 compared to the previous average buy price of 29.328. This is 6.8% higher than average price of previous purchases of GLPG. |
| HCM - HUTCHMED China Ltd | BUY | 54 @ USD 14.42 | USD 779 | The ETF bought 54 new shares of HCM (HUTCHMED China Ltd). The shares were bought for an average price of 14.42 compared to the previous average buy price of 15.3939. This is -6.3% lower than average price of previous purchases of HCM. |
| HCM - Hitachi Construction Machinery Co. Ltd | BUY | 54 @ USD 14.42 | USD 779 | The ETF bought 54 new shares of HCM (Hitachi Construction Machinery Co. Ltd). The shares were bought for an average price of 14.42 compared to the previous average buy price of 15.3939. This is -6.3% lower than average price of previous purchases of HCM. |
| LYEL - Lyell Immunopharma Inc | BUY | 32 @ USD 24 | USD 768 | The ETF bought 32 new shares of LYEL (Lyell Immunopharma Inc). The shares were bought for an average price of 24 compared to the previous average buy price of 6.98937. This is 243.4% higher than average price of previous purchases of LYEL. |
| ALT - Altitude Group Plc | BUY | 145 @ USD 5.26 | USD 763 | The ETF bought 145 new shares of ALT (Altitude Group Plc). The shares were bought for an average price of 5.26 compared to the previous average buy price of 5.15267. This is 2.1% higher than average price of previous purchases of ALT. |
| SIGA - SIGA Technologies Inc | BUY | 120 @ USD 6.06001 | USD 727 | The ETF bought 120 new shares of SIGA (SIGA Technologies Inc). The shares were bought for an average price of 6.06001 compared to the previous average buy price of 6.73077. This is -10.0% lower than average price of previous purchases of SIGA. |
| TRDA - Entrada Therapeutics Inc | BUY | 70 @ USD 10.27 | USD 719 | The ETF bought 70 new shares of TRDA (Entrada Therapeutics Inc). The shares were bought for an average price of 10.27 compared to the previous average buy price of 7.81022. This is 31.5% higher than average price of previous purchases of TRDA. |
| RCKT - Rocket Pharmaceuticals Inc | BUY | 184 @ USD 3.42 | USD 629 | The ETF bought 184 new shares of RCKT (Rocket Pharmaceuticals Inc). The shares were bought for an average price of 3.42 compared to the previous average buy price of 4.92769. This is -30.6% lower than average price of previous purchases of RCKT. |
| BCYC - Bicycle Therapeutics Ltd | BUY | 81 @ USD 7.47999 | USD 606 | The ETF bought 81 new shares of BCYC (Bicycle Therapeutics Ltd). The shares were bought for an average price of 7.47999 compared to the previous average buy price of 8.384. This is -10.8% lower than average price of previous purchases of BCYC. |
| VNDA - Vanda Pharmaceuticals Inc | BUY | 110 @ USD 5.36001 | USD 590 | The ETF bought 110 new shares of VNDA (Vanda Pharmaceuticals Inc). The shares were bought for an average price of 5.36001 compared to the previous average buy price of 4.87022. This is 10.1% higher than average price of previous purchases of VNDA. |
| AVXL - Anavex Life Sciences Corp | BUY | 148 @ USD 3.82999 | USD 567 | The ETF bought 148 new shares of AVXL (Anavex Life Sciences Corp). The shares were bought for an average price of 3.82999 compared to the previous average buy price of 8.94425. This is -57.2% lower than average price of previous purchases of AVXL. |
| ALLO - Allogene Therapeutics Inc | BUY | 380 @ USD 1.46 | USD 555 | The ETF bought 380 new shares of ALLO (Allogene Therapeutics Inc). The shares were bought for an average price of 1.46 compared to the previous average buy price of 1.33247. This is 9.6% higher than average price of previous purchases of ALLO. |
| AUTL - Autolus Therapeutics Ltd | BUY | 376 @ USD 1.41 | USD 530 | The ETF bought 376 new shares of AUTL (Autolus Therapeutics Ltd). The shares were bought for an average price of 1.41 compared to the previous average buy price of 1.7999. This is -21.7% lower than average price of previous purchases of AUTL. |
| ACIU - AC Immune Ltd | BUY | 173 @ USD 2.99 | USD 517 | The ETF bought 173 new shares of ACIU (AC Immune Ltd). The shares were bought for an average price of 2.99 compared to the previous average buy price of 2.47625. This is 20.7% higher than average price of previous purchases of ACIU. |
| AVIR - Atea Pharmaceuticals Inc | BUY | 144 @ USD 3.1 | USD 446 | The ETF bought 144 new shares of AVIR (Atea Pharmaceuticals Inc). The shares were bought for an average price of 3.1 compared to the previous average buy price of 3.30422. This is -6.2% lower than average price of previous purchases of AVIR. |
| EDIT - Editas Medicine Inc | BUY | 165 @ USD 2.41 | USD 398 | The ETF bought 165 new shares of EDIT (Editas Medicine Inc). The shares were bought for an average price of 2.41 compared to the previous average buy price of 2.70875. This is -11.0% lower than average price of previous purchases of EDIT. |
| OABI - OmniAb Inc. | BUY | 214 @ USD 1.81001 | USD 387 | The ETF bought 214 new shares of OABI (OmniAb Inc.). The shares were bought for an average price of 1.81001 compared to the previous average buy price of 1.89024. This is -4.2% lower than average price of previous purchases of OABI. |
| HUMA - Humacyte Inc | BUY | 282 @ USD 1.35 | USD 381 | The ETF bought 282 new shares of HUMA (Humacyte Inc). The shares were bought for an average price of 1.35 compared to the previous average buy price of 2.12959. This is -36.6% lower than average price of previous purchases of HUMA. |
| VYGR - Voyager Therapeutics Inc | BUY | 89 @ USD 4.08999 | USD 364 | The ETF bought 89 new shares of VYGR (Voyager Therapeutics Inc). The shares were bought for an average price of 4.08999 compared to the previous average buy price of 3.8785. This is 5.5% higher than average price of previous purchases of VYGR. |
| ARCT - Arcturus Therapeutics Holdings Inc | BUY | 49 @ USD 6.78998 | USD 333 | The ETF bought 49 new shares of ARCT (Arcturus Therapeutics Holdings Inc). The shares were bought for an average price of 6.78998 compared to the previous average buy price of 13.7777. This is -50.7% lower than average price of previous purchases of ARCT. |
| MXCT - MaxCyte Inc | BUY | 185 @ USD 1.76 | USD 326 | The ETF bought 185 new shares of MXCT (MaxCyte Inc). The shares were bought for an average price of 1.76 compared to the previous average buy price of 2.11843. This is -16.9% lower than average price of previous purchases of MXCT. |
| ALEC - Alector Inc | BUY | 184 @ USD 1.33001 | USD 245 | The ETF bought 184 new shares of ALEC (Alector Inc). The shares were bought for an average price of 1.33001 compared to the previous average buy price of 1.84476. This is -27.9% lower than average price of previous purchases of ALEC. |
| MRSN - Mersana Therapeutics Inc | BUY | 8 @ USD 27.4299 | USD 219 | The ETF bought 8 new shares of MRSN (Mersana Therapeutics Inc). The shares were bought for an average price of 27.4299 compared to the previous average buy price of 0.794797. This is 3,351.2% higher than average price of previous purchases of MRSN. |
| FATE - Fate Therapeutics Inc | BUY | 189 @ USD 1.14001 | USD 215 | The ETF bought 189 new shares of FATE (Fate Therapeutics Inc). The shares were bought for an average price of 1.14001 compared to the previous average buy price of 1.16897. This is -2.5% lower than average price of previous purchases of FATE. |
| MGNX - MacroGenics Inc | BUY | 107 @ USD 1.52999 | USD 164 | The ETF bought 107 new shares of MGNX (MacroGenics Inc). The shares were bought for an average price of 1.52999 compared to the previous average buy price of 1.56542. This is -2.3% lower than average price of previous purchases of MGNX. |
| PLRX - Pliant Therapeutics Inc | BUY | 100 @ USD 1.60999 | USD 161 | The ETF bought 100 new shares of PLRX (Pliant Therapeutics Inc). The shares were bought for an average price of 1.60999 compared to the previous average buy price of 1.5063. This is 6.9% higher than average price of previous purchases of PLRX. |
| BMEA - Biomea Fusion Inc | BUY | 120 @ USD 1.09 | USD 131 | The ETF bought 120 new shares of BMEA (Biomea Fusion Inc). The shares were bought for an average price of 1.09 compared to the previous average buy price of 1.67254. This is -34.8% lower than average price of previous purchases of BMEA. |
| STRO - Sutro Biopharma | BUY | 136 @ USD 0.919396 | USD 125 | The ETF bought 136 new shares of STRO (Sutro Biopharma). The shares were bought for an average price of 0.919396 compared to the previous average buy price of 0.89707. This is 2.5% higher than average price of previous purchases of STRO. |
| OKUR - OKUR | BUY | 21 @ USD 3.01004 | USD 63 | The ETF bought 21 new shares of OKUR (OKUR). The shares were bought for an average price of 3.01004 compared to the previous average buy price of 5.91605. This is -49.1% lower than average price of previous purchases of OKUR. |
| - - | HOLD | 0 @ USD 0 | USD 0 | |
| THRD - Third Harmonic Bio Inc. | HOLD | 0 @ USD 0.0300173 | USD 0 | The current share valuation price of THRD based on adjusted close was USD 0.0300173. The average price that THRD shares were previous bought at was USD 5.06885. The current market price is -99.4% lower than average price they were purchased at. USD 0 compared to the previous valuation of Third Harmonic Bio Inc. however if the holding was sold on 2025-11-28 this would crystalise an overall loss. |